Consensus Ovintiv Inc.

Equities

OVV

US69047Q1022

Market Closed - Nyse 04:00:02 2024-05-17 pm EDT 5-day change 1st Jan Change
49.79 USD +0.99% Intraday chart for Ovintiv Inc. -0.30% +13.37%

Evolution of the average Target Price on Ovintiv Inc.

Price target over the last 5 years

History of analyst recommendation changes

f8e204a1e7eb3ad9.b1agDVT3lPy8-uqxzlQ5ot1W_AEq-VjJwn77NR0ARQU.OCfPQSOi_6_srLjm_TVBy54aqHhIvhOqlhuPTEwyczIXMfFLNo2mt47LgQ~64fd454073a67a6d78ec9792442b1429
Ovintiv Insider Sold Shares Worth $600,000, According to a Recent SEC Filing MT
Ovintiv Maintained at Buy at UBS Following First-Quarter Results; Price Target Raised to US$70.00 MT
UBS Adjusts Ovintiv Price Target to $70 From $69, Maintains Buy Rating MT
Mizuho Securities Raises Price Target on Ovintiv to $64 From $58, Keeps Buy Rating MT
Ovintiv's Price Target Raised to US$62 from US$60 by RBC Capital Markets MT
RBC Raises Price Target on Ovintiv to $62 From $60, Keeps Sector Perform Rating MT
Ovintiv Maintained at Sector Perform at RBC Following Q1 Results; Price Target Kept at US$60.00 MT
Ovintiv Maintained at Outperform at National Bank Following First-Quarter Results; Price Target Kept at US$68.00 MT
Ovintiv Maintained at Buy at TPH Following First-Quarter Results; Price Target at US$66.00 MT
Ovintiv Receives Sector Perform Rating from RBC Capital Markets Ahead of Q1 Results MT
Morgan Stanley Raises Price Target on Ovintiv to $53 From $49, Keeps Equalweight Rating MT
Ovintiv Maintained at Buy at TPH Ahead of Q1 Results; Price Target at US$66.00 MT
UBS Raises Ovintiv Price Target to $69 From $62, Maintains Buy Rating MT
RBC Raises Price Target on Ovintiv to $61 From $49, Keeps Sector Perform Rating MT
Goldman Sachs Adjusts Ovintiv's Price Target to $56 From $47, Keeps Neutral Rating MT
Mizuho Securities Trims Price Target on Ovintiv to $58 From $59, Maintains Buy Rating MT
Citigroup Raises Price Target on Ovintiv to $58 From $52, Keeps Buy Rating MT
Wells Fargo Raises Price Target on Ovintiv to $54 From $44, Maintains Equalweight Rating MT
UBS Raises Ovintiv Price Target to $62 From $57, Maintains Buy Rating MT
Ovintiv Maintained at Buy at UBS Following Q4 Results; Price Target Raised to US$62.00 MT
RBC Lifts Price Target on Ovintiv to $49 From $48 After 'Strong' Q4, Keeps Sector Perform Rating MT
Ovintiv Maintained at Buy at TPH Following Q4 Results; Price Target Kept at US$62.00 MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
49.79 USD
Average target price
62.58 USD
Spread / Average Target
+25.69%
High Price Target
71 USD
Spread / Highest target
+42.60%
Low Price Target
52.74 USD
Spread / Lowest Target
+5.92%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Ovintiv Inc.

UBS
Mizuho Securities
RBC Capital Markets
Tudor Pickering Holt & Co.
National Bank Financial
Morgan Stanley
Goldman Sachs
Citigroup
Wells Fargo Securities
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
  1. Stock Market
  2. Equities
  3. OVV Stock
  4. Consensus Ovintiv Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW